Clinical Application and Long-Term Follow-Up Study of Porcine Acellular Dermal Matrix Combined With Autoskin Grafting

2010 ◽  
Vol 31 (2) ◽  
pp. 280-285 ◽  
Author(s):  
Chen Jiong ◽  
Chai Jiake ◽  
Han Chunmao ◽  
Pan Yingen ◽  
Wu Qiuhe ◽  
...  
Keyword(s):  
Clinical Application ◽  
Acellular Dermal Matrix ◽  
Dermal Matrix ◽  
Follow Up Study ◽  
Long Term Follow Up ◽  
Porcine Acellular Dermal Matrix ◽  
Acellular Dermal

A Long-term Follow-up Study of Acellular Dermal Matrix With Thin Autograft in Burns Patients

2011 ◽  
Vol 67 (4) ◽  
pp. 346-351 ◽  
Author(s):  
Yunchuan Pan ◽  
Zunhong Liang ◽  
Su Yuan ◽  
Jiaqin Xu ◽  
Jun Wang ◽  
...  
Keyword(s):  
Acellular Dermal Matrix ◽  
Dermal Matrix ◽  
Follow Up Study ◽  
Long Term Follow Up ◽  
Acellular Dermal

Abdominal wall repair using human acellular dermal matrix: a follow-up study

2009 ◽  
Vol 198 (5) ◽  
pp. 650-657 ◽  
Author(s):  
Edward I. Lee ◽  
Chuma J. Chike-Obi ◽  
Patricio Gonzalez ◽  
Ramon Garza ◽  
Mimi Leong ◽  
...  
Keyword(s):  
Abdominal Wall ◽  
Acellular Dermal Matrix ◽  
Dermal Matrix ◽  
Abdominal Wall Repair ◽  
Follow Up Study ◽  
Acellular Dermal ◽  
Human Acellular Dermal Matrix

scholarly journals Evaluation of Complication Rates after Breast Surgery Using Acellular Dermal Matrix: Median Follow-Up of Three Years

2017 ◽  
Vol 2017 ◽  
pp. 1-9 ◽  
Author(s):  
Felix J. Paprottka ◽  
Nicco Krezdorn ◽  
Heiko Sorg ◽  
Sören Könneker ◽  
Stiliano Bontikous ◽  
...  
Keyword(s):  
Capsular Contracture ◽  
Composite Endpoint ◽  
Acellular Dermal Matrix ◽  
Complication Rates ◽  
Dermal Matrix ◽  
Long Term Follow Up ◽  
Retrospective Data Collection ◽  
Dermal Matrices ◽  
Acellular Dermal

Introduction. Acellular dermal matrices (ADMs) are now commonly used for breast reconstruction surgery. There are various products available: ADMs derived from human (HADM), porcine (PADM), or bovine (BADM) sources. Detailed long-term follow-up studies are necessary to detect differences in complication rates between these products. Material and Methods. From 2010 to 2015, forty-one patients underwent 52 ADM-breast reconstructions in our clinic, including oncologic breast reconstructions and breast augmentation revisions (n=52). 15x HADMs (Epiflex®/DIZG), 21x PADMs (Strattice®/LifeCell), and 16x BADMs (Tutomesh®/RTI Surgical) were implanted. Retrospective data collection with median follow-up of 36 months (range: 12–54 months) was performed. Results. Overall complication rate was 17% after ADM implantation (HADM: 7%; PADM: 14%; BADM: 31%). In a composite endpoint of complications and Red Breast Syndrome, a lower event probability was observed between BADMs, PADMs, and HADMs (44%, 19%, and 7%, resp.; p=0.01 for the trend). Furthermore, capsular contracture occurred in 6%, more frequently as compared to the current literature. Conclusions. When ADM-based reconstruction is indicated, the authors suggest primarily the use of HADMs and secondary the use of PADMs. It is shown that BADMs have the highest complication probability within our patient cohort; nevertheless, BADMs convey physical advantages in terms of flexibility and better aesthetic outcomes. The indication for the use of ADMs should be filled for each case individually.

Sign in / Sign up

Export Citation Format

Share Document